This compound is a pharmaceutical impurity, specifically this compound, used as a reference standard or process-related substance in the quality control of pharmaceutical manufacturing. It contains an amide, aromatic ring, and heterocyclic ring system, with moderate polarity and lipophilicity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Benzoic acid, 2-(hexahydro-1-methyl-1H-azepin-4-yl)hydrazide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
7,7'-[Butane-1,4-diylbis(oxy)]di(3,4-dihydroquinolin-2(1H)-one)
pharmaceutical raw material
Des(1-hydroxy-1-methylethyl)-(1-methylethenyl)-olmesartan medoxomil
pharmaceutical raw material
Dolastatin 10
pharmaceutical raw material
Paroxetine hydrochloride hemihydrate
pharmaceutical raw material
Calcium bis[(3R,5R)-7-({(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl}amino)-3,5-dihydroxyheptanoate]
pharmaceutical raw material
Exubera
pharmaceutical raw material
N'-(1-methylazepan-4-yl)benzohydrazide
HJCSHXABAVJCGJ-UHFFFAOYSA-N
CN1CCCC(CC1)NNC(=O)C2=CC=CC=C2
Sourcing Benzoic acid, 2-(hexahydro-1-methyl-1H-azepin-4-yl)hydrazide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.